#Daratumumab Effective in Light Chain Amyloidosis

"My experience with this drug is very positive and it [daratumumab] has become our #standard of #care for newly diagnosed patients," commented Mathew Maurer, MD Columbia University 

#Genmab $GMAB $JNJ

https://t.co/RluZLDOuNw